Phase I study of intravenous and intramuscular MDX 1303 in volunteers

Trial Profile

Phase I study of intravenous and intramuscular MDX 1303 in volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 06 Dec 2011

At a glance

  • Drugs MDX 1303 (Primary) ; MDX 1303 (Primary)
  • Indications Anthrax
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 06 Dec 2011 Results published in a PharmAthene media release.
    • 08 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top